Discover
ASMB
Assembly Biosciences, Inc.
23.53
2 x 16.81
2 x 29.22
bid
ask
+
0.71
3.11%
2 @ 04:00 PM
23.53 +0.00 (0.00%)
| Ytd | -30.81% | |
| 1y | -12.27% |
22.84
day range
23.58
22.18
52 week range
38.50
| Open | 23.00 | Prev Close | 22.82 | Low | 22.84 | High | 23.58 | Mkt Cap | 479.08M |
| Vol | 170.49K | Avg Vol | 279.78K | EPS | 1.07 | P/E | 21.99 | Forward P/E | -2.12 |
| Beta | 0.59 | Short Ratio | 0.41 | Inst. Own | 18.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 28.64 | 200-d Avg | 28.15 | 1yr Est | 35.50 |
| Income Statement | |||
| Operating Expenses | 19.72M | ||
| Research and Development Expense | 14.92M | ||
| Selling, General and Administrative Expense | 4.80M | ||
| Operating Income | -19.72M | ||
| Net Income | -3.86M | ||
| Net Income Common Stock | -3.86M | ||
| Net Income Common Stock (USD) | -3.86M | ||
| Consolidated Income | -3.86M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -3.86M | ||
| Earning Before Interest & Taxes (USD) | -3.86M | ||
| Weighted Average Shares | 18.85M | ||
| Weighted Average Shares Diluted | 18.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 32.29M | ||
| Cash and Equivalents (USD) | 32.29M | ||
| Investments | 288.08M | ||
| Investments Current | 288.08M | ||
| Trade and Non-Trade Receivables | 822.00K | ||
| Current Assets | 327.98M | ||
| Property, Plant & Equipment Net | 2.54M | ||
| Total Assets | 330.83M | ||
| Debt Current | 612.00K | ||
| Total Debt | 2.35M | ||
| Current Liabilities | 23.45M | ||
| Debt Non-Current | 1.74M | ||
| Total Liabilities | 25.18M | ||
| Accumulated Retained Earnings (Deficit) | -844.98M | ||
| Accumulated Other Comprehensive Income | -623.00K | ||
| Shareholders Equity | 305.65M | ||
| Shareholders Equity (USD) | 305.65M | ||
| Assets Non-Current | 2.85M | ||
| Total Debt (USD) | 2.35M | ||
| Deferred Revenue | 16.30M | ||
| Liabilities Non-Current | 1.74M | ||
| Trade and Non-Trade Payables | 1.18M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.00K | ||
| Net Cash Flow from Financing | 108.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.17M | ||
| Issuance (Purchase) of Equity Shares | 108.74M | ||
| Net Cash Flow from Investing | -92.08M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -92.08M | ||
| Net Cash Flow from Operations | -15.49M | ||
| Share Based Compensation | 2.42M | ||